DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tetrahydrouridine is an investigational drug.
There have been 17 clinical trials for Tetrahydrouridine. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2000.
The most common disease conditions in clinical trials are Lung Neoplasms, Head and Neck Neoplasms, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), EpiDestiny, Inc., and City of Hope Medical Center.
Recent Clinical Trials for Tetrahydrouridine
|Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult Subjects||EpiDestiny, Inc.||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||National Institutes of Health (NIH)||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||EpiDestiny, Inc.||Phase 1|